Cargando…
A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models
Glioblastoma (GBM) is the most common malignant brain tumor. Available treatments have limited success because most patients develop chemoresistance. Alternative strategies are required to improve anticancer effects of current chemotherapeutics while limiting resistance. Successful targeting of micr...
Autores principales: | Sadeghipour, Negar, Kumar, Sukumar Uday, Massoud, Tarik F., Paulmurugan, Ramasamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283442/ https://www.ncbi.nlm.nih.gov/pubmed/35835978 http://dx.doi.org/10.1038/s41598-022-16219-x |
Ejemplares similares
-
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
por: Afjei, Rayhaneh, et al.
Publicado: (2022) -
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
por: Malhotra, Meenakshi, et al.
Publicado: (2018) -
Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
por: Wang, Huaijun, et al.
Publicado: (2022) -
MicroRNAs - A New Generation Molecular Targets for Treating Cellular Diseases
por: Paulmurugan, Ramasamy
Publicado: (2013) -
Therapeutic Evaluation of microRNAs by Molecular Imaging
por: Sekar, Thillai V., et al.
Publicado: (2013)